Linda M Rubinstein - Net Worth and Insider Trading

Linda M Rubinstein Net Worth

The estimated net worth of Linda M Rubinstein is at least $93,000 dollars as of 2024-05-12. Linda M Rubinstein is the CFO of Adverum Biotechnologies Inc and owns about 10,000 shares of Adverum Biotechnologies Inc (ADVM) stock worth over $93,000. Details can be seen in Linda M Rubinstein's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Linda M Rubinstein has not made any transactions after 2023-06-07 and currently still holds the listed stock(s).

Transaction Summary of Linda M Rubinstein

To

Linda M Rubinstein Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Linda M Rubinstein owns 4 companies in total, including Five Prime Therapeutics Inc (FPRX) , Biocept Inc (BIOCQ) , and Alector Inc (ALEC) among others .

Click here to see the complete history of Linda M Rubinstein’s form 4 insider trades.

Insider Ownership Summary of Linda M Rubinstein

Ticker Comapny Transaction Date Type of Owner
FPRX Five Prime Therapeutics Inc 2018-04-13 Interim CFO
BIOCQ Biocept Inc 2021-07-16 director
ALEC Alector Inc 2021-09-08 Interim Chief Financial Ofcr
2023-06-07 Chief Financial Officer

Linda M Rubinstein Latest Holdings Summary

Linda M Rubinstein currently owns a total of 1 stock. Linda M Rubinstein owns 10,000 shares of Adverum Biotechnologies Inc (ADVM) as of June 7, 2023, with a value of $93,000.

Latest Holdings of Linda M Rubinstein

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ADVM Adverum Biotechnologies Inc 2023-06-07 10,000 9.30 93,000

Holding Weightings of Linda M Rubinstein


Linda M Rubinstein Form 4 Trading Tracker

According to the SEC Form 4 filings, Linda M Rubinstein has made a total of 1 transactions in Adverum Biotechnologies Inc (ADVM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Adverum Biotechnologies Inc is the acquisition of 10,000 shares on June 7, 2023, which cost Linda M Rubinstein around $145,000.

Insider Trading History of Linda M Rubinstein

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Linda M Rubinstein Trading Performance

GuruFocus tracks the stock performance after each of Linda M Rubinstein's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Linda M Rubinstein is 20.27%. GuruFocus also compares Linda M Rubinstein's trading performance to market benchmark return within the same time period. The performance of stocks bought by Linda M Rubinstein within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Linda M Rubinstein's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Linda M Rubinstein

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 14.86
Relative Return to S&P 500(%) 11.78

Linda M Rubinstein Ownership Network

Ownership Network List of Linda M Rubinstein

No Data

Ownership Network Relation of Linda M Rubinstein


Linda M Rubinstein Owned Company Details

What does Five Prime Therapeutics Inc do?

Who are the key executives at Five Prime Therapeutics Inc?

Linda M Rubinstein is the Interim CFO of Five Prime Therapeutics Inc. Other key executives at Five Prime Therapeutics Inc include 10 percent owner Biotechnology Value Fund L P , 10 percent owner Bvf Gp Holdings Llc , and 10 percent owner Bvf Partners L P/il .

Five Prime Therapeutics Inc (FPRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Five Prime Therapeutics Inc (FPRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Five Prime Therapeutics Inc (FPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Five Prime Therapeutics Inc (FPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Five Prime Therapeutics Inc Insider Transactions

No Available Data

Linda M Rubinstein Mailing Address

Above is the net worth, insider trading, and ownership report for Linda M Rubinstein. You might contact Linda M Rubinstein via mailing address: 25861 Industrial Blvd, Hayward Ca 94545.

Discussions on Linda M Rubinstein

No discussions yet.